Royal colleges need modernisation.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to M Brudenell.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Circulating levels of SP1 were measured in 20 insulin dependent diabetic women during the third trimester of pregnancy. With one exception, SP1 levels were between the 80 per cent confidence limits of the normal range. The exception was a patient who was delivered of a normal infant at 37 weeks but had consistently low levels of SP1 from 32 weeks until delivery, suggesting a specific defect in SP1 synthesis.
Plasma human placental lactogen (HPL) concentrations have been measured at frequent intervals over 24 hours in 24 normal women, 13 chemical and 13 insulin dependent diabetic patients during the third trimester of pregnancy. Most of the women studied displayed variation in HPL levels during the day, but there was no evidence of a diurnal rhythm, nor significant changes following meals or during the nocturnal fast. The mean plasma HPL concentrations over 24 hours in the chemical and insulin dependent diabetic patients (5-9+/-SD 1-3 and 5-9+/-1-7 microng/ml respectively) were greater than those in normal women (5-1+/-1-2 microng/ml) but this difference was not significant. No significant change in plasma HPL concentrations was observed during a five-hour oral glucose tolerance test in either the normal or chemical diabetic group. It is suggested that in normal pregnant women HPL does not itself contribute to glucose homeostasis but acts as a 'regulator' which alters the actions of certain maternal hormones to achieve a favourable environment for fetal growth.
Explore the source record for details and available documents.
A prospective study has been carried out of placental lactogen levels in pregnancy complicated by diabetes mellitus. The levels were higher than those in normal pregnant subjects; the higher levels were related to increased placental and fetal weight but more closely to the former; and lower levels were found when there was clinical evidence of placental dysfunction. Those patients requiring the largest insulin increment for the control of their diabetes in the pregnancy have placental lactogen levels in the higher range.
Explore the source record for details and available documents.